Kamada (KMDA) Change in Account Payables (2012 - 2026)
Kamada (KMDA) reported Change in Account Payables of -$1.4 million for Q1 2026, up 61.42% on a YoY basis from -$895803.0 in Q1 2025, and up 57.13% quarter-over-quarter from -$3.4 million in Q4 2025.
Kamada (KMDA) Change in Account Payables (2012 - 2026) Analysis & Trends
Kamada has reported Change in Account Payables for 15 years, with the latest figure at -$1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 61.42% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at -$4.6 million (down 172.94% YoY), and the FY2025 full-year result was -$6.9 million, down 660.36% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$1.4 million, up from -$3.4 million in the prior quarter.
- The five-year high for Change in Account Payables was $12.0 million in Q4 2024, with the low at -$13.6 million in Q1 2022.
- Historically, Change in Account Payables has averaged -$905753.8 across 5 years, with a median of -$6712.0 in 2023.
- Annual changes were most pronounced in 2023 — Change in Account Payables surged 985417.24% — and 2024, when it plunged 130784.98%.
- Kamada's Change in Account Payables stood at $1160.0 in 2022, then surged by 985417.24% to $11.4 million in 2023, then increased by 4.73% to $12.0 million in 2024, then tumbled by 128.17% to -$3.4 million in 2025, then soared by 57.13% to -$1.4 million in 2026.
- The last three Change in Account Payables figures came in at -$1.4 million (Q1 2026), -$3.4 million (Q4 2025), and $634000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | -1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.45 Mn |
| Mar 31, 2026 | -1.45 Mn |
| Dec 31, 2025 | -3.37 Mn |
| Dec 31, 2025 | -3.37 Mn |
| Sep 30, 2025 | 634,000.00 |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | -383,000.00 |
| Jun 30, 2025 | -383,000.00 |
| Mar 31, 2025 | -3.75 Mn |
| Mar 31, 2025 | -3.75 Mn |
| Dec 31, 2024 | 11.97 Mn |
| Dec 31, 2024 | 11.97 Mn |
| Sep 30, 2024 | -5.66 Mn |
| Sep 30, 2024 | -5.66 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | -8.79 Mn |
| Mar 31, 2024 | -8.79 Mn |
| Dec 31, 2023 | 11.43 Mn |
| Dec 31, 2023 | 11.43 Mn |